Differences between donepezil (Aricept) and memantine in the treatment of Alzheimer's disease

Donepezil (trade name: Aricept) and memantine (Memantine) are both commonly used drugs for Alzheimer's disease (AD), but their mechanisms of action are different. Donepezil is an acetylcholinesterase inhibitor that inhibits the breakdown of acetylcholine and increases acetylcholine levels in the brain, thereby improving cognitive function and memory. Memantine is an NMDA receptor antagonist that regulates glutamate activity to prevent excitotoxicity from causing damage to neurons. It is mainly used in patients with moderate to severe AD.

Donepezil is suitable for patients with mild to moderate Alzheimer's disease and can also be used as adjuvant treatment for some moderately severe patients; its main goal is to improve early cognitive decline and daily living abilities. Memantine is more commonly used in patients with moderate to severe AD, especially when the efficacy of acetylcholinesterase inhibitors is limited. It can be used alone or in combination with donepezil to delay neurodegenerative damage and symptom worsening.

Donepezil improves memory, attention, and cognitive function by increasing acetylcholine levels. The onset of effects is usually observed over weeks to months, but it does not prevent the long-term progression of the disease. Memantine protects neurons by inhibiting over-excited nerve signals, reducing behavioral symptoms and cognitive deterioration, and is suitable for moderate to severe patients to maintain daily life functions. The efficacy of the two is complementary, with donepezil favoring cognitive improvement and memantine favoring neuroprotection and symptom control.

Common side effects of donepezil include nausea, vomiting, diarrhea, insomnia and slowed heart rate, and some patients need to adjust the dose or take it in divided doses. The side effects of memantine are relatively mild, mainly dizziness, headache and constipation, and it is less irritating to the gastrointestinal tract. Taken together, donepezil is suitable for early cognitive improvement, while memantine is more suitable for moderate to severe patients or combined treatment options to improve overall efficacy and quality of life.

Reference link:https://www.drugs.com